Page last updated: 2024-09-05

alagebrium and quinapril

alagebrium has been researched along with quinapril in 1 studies

Compound Research Comparison

Studies
(alagebrium)
Trials
(alagebrium)
Recent Studies (post-2010)
(alagebrium)
Studies
(quinapril)
Trials
(quinapril)
Recent Studies (post-2010) (quinapril)
83103165222047

Protein Interaction Comparison

ProteinTaxonomyalagebrium (IC50)quinapril (IC50)
Angiotensin-converting enzyme Homo sapiens (human)0.0083
Angiotensin-converting enzymeOryctolagus cuniculus (rabbit)0.11
Angiotensin-converting enzyme 2 Homo sapiens (human)0.0083

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bierhaus, A; Cooper, ME; Gray, SP; Jandeleit-Dahm, KA; Jiaze, L; Pickering, R; Soro-Paavonen, A; Thomas, MC; Tikellis, C; Tsorotes, D; Watson, AM; Wong, B1

Other Studies

1 other study(ies) available for alagebrium and quinapril

ArticleYear
Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.
    Diabetes, 2012, Volume: 61, Issue:8

    Topics: Albuminuria; Animals; Apolipoproteins E; Diabetes Mellitus, Experimental; Fibrosis; Glomerular Mesangium; Glomerulonephritis; Glycation End Products, Advanced; Male; Mice; Mice, Knockout; Nephritis; Oxidative Stress; Quinapril; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Tetrahydroisoquinolines; Thiazoles

2012